RenovoRx, Inc. (RNXT)
1.27
-0.01
(-0.78%)
USD |
NASDAQ |
Oct 12, 14:56
RenovoRx Profit Margin (Quarterly) : -320.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -320.2% |
| March 31, 2026 | -625.4% |
| December 31, 2025 | -1.24K% |
| September 30, 2025 | -1.09K% |
| Date | Value |
|---|---|
| June 30, 2025 | -686.0% |
| March 31, 2025 | -1.23K% |
| December 31, 2024 | -6.69K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | -135.8% |
| Travere Therapeutics, Inc. | -20.52% |
| REGENXBIO, Inc. | 21.02% |
| Krystal Biotech, Inc. | 45.94% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -138.4% |
| Return on Assets | -105.1% |
| Return on Invested Capital | -134.5% |
| Gross Profit Margin (Quarterly) | 84.27% |
| Operating Margin (Quarterly) | -368.4% |
| Return on Net Operating Assets | -1.03K% |